Table 1 Descriptive Statistics (n = 5790)
Variable | Â |
|---|---|
Age: mean (range) | 57.40 (21-94) |
TNM Stage: | N (%) |
0 | 736 (12.7%) |
I | 2625 (45.3%) |
IIa | 1298 (22.4%) |
IIb | 729 (12.6%) |
IIIa | 239 (4.1%) |
IIIb | 116 (2.0%) |
IIIc | 47 (.8%) |
Estrogen receptor positive | 4268 (73.7%) |
Progesterone receptor positive | 3628 (62.7%) |
Treatment: | N (%) |
Surgery only | 420 (7.3%) |
Surgery/radiation | 2764 (47.7%) |
Surgery/chemotherapy | 640 (11.1%) |
Surgery/radiation/chemotherapy | 1966 (34.0%) |
Anthracycline regimen | 1973 (75.7%) |
Non-anthracycline regimen | 646 (24.3%) |
Tamoxifen | 3554 (61.4%) |
Follow up years: mean (range) | 7.02 (.20, 18.15) |
Vital Status: | N (%) |
Alive, NED* | 4741 (81.9%) |
Alive with this cancer | 123 (2.1%) |
Alive with other cancer | 62 (1.1%) |
Expired, NED | 354 (6.1%) |
Expired with this cancer | 388 (6.7%) |
Expired with other cancer | 121 (2.1%) |
Expired, treatment complications | 1 (.0%) |